Management of a patient with chronic venous insufficiency

A lot of recommendations has been published regarding the treatment of chronic venous disease. At the same time, none of these documents reflects the complete «path» of the patient from the stage of the initial visit (diagnosis) to the choice of the optimal treatment option. Therefore, the creation of a protocol that would take into account the most modern and proven effective approaches to diagnosis and treatment, and the individual characteristics of each clinical case is an urgent task. The aim of the publication is to create a practice-oriented instruction for the diagnosis, comprehensive treatment and prevention of chronic venous insufficiency. The management of a patient with chronic venous insufficiency is presented in the «AngioLife Venous Protocol^®», a set of clear practical recommendations for vascular surgeon and phlebologist. This protocol is based on our own practical experience, existing protocols and guidelines for the treatment of patients with chronic venous insufficiency. The protocol includes four stages of a set of medical measures, the purpose of which is to form a clear program of further examination and treatment of the patient. Adherence to all the recommendations specified in the protocol allows to obtain satisfactory functional and cosmetic results of treatment of patients with chronic venous insufficiency with minimal risk of recurrence.

References

1. McArdle M., Hernandez-Vila E.A. (2017) Management of chronic venous disease. Texas Heart Institute J., 44(5): 347–349.
2. Belramman A., Bootun R., Lane T.R., Davies A.H. (2019) Endovenous management of varicose veins. Angiology, 70(5): 388–396.
3. Wittens C., Davies A.H., Bækgaard N. et al.; ESVS Guidelines Committee (2015) Editor’s choice–management of chronic venous disease: clinical practice guidelines of the European Society for Vascular Surgery (ESVS). Eur. J. Vasc. Endovasc. Surg., 49(6): 678–737.
4. Carradice D., Forsyth J., Mohammed A. et al. (2018) Compliance with NICE guidelines when commissioning varicose vein procedures. BJS Open, 2(6): 419–425.
5. Lurie F., Lal B.K., Antignani P.L. et al. (2019) Compression therapy after invasive treatment of superficial veins of the lower extremities: Clinical practice guidelines of the American Venous Forum, Society for Vascular Surgery, American College of Phlebology, Society for Vascular Medicine, and International Union of Phlebology. J. Vasc. Surg. Venous Lymph. Dis., 7(1): 17–28.
6. Raetz J., Wilson M., Collins K. (2019) Varicose veins: Diagnosis and treatment. Am. Fam. Phys., 99(11): 682–688.
7. Davies A.H. (2019) The seriousness of chronic venous disease: a review of real-world evidence. Advances in Therapy, 36(1): 5–12.
8. Garcia R., Labropoulos N. (2018) Duplex ultrasound for the diagnosis of acute and chronic venous diseases. Surg. Clin., 98(2): 201–218.
9. Labropoulos N. (2019) How does chronic venous disease progress from the first symptoms to the advanced stages? A review. Advances in Therapy, 36(1): 13–19.
10. Kheirelseid E.A., Crowe G., Sehgal R. et al. (2018) Systematic review and meta-analysis of randomized controlled trials evaluating long-term outcomes of endovenous management of lower extremity varicose veins. J. Vasc. Surg. Venous Lymph. Dis., 6(2): 256–270.
11. Suzdalenko O.V., Voloshyn O.M. (2019) EVLT and Foam-form Sclerotherapy as a C6 Stage Varicose Treatment. Eur. J. Vasc. Endovasc. Surg., 58(6): 478–479.
12. Voloshyn O., Suzdalenko O. (2019) Early Versus Deferred Endovenous Superficial Venous Treatment in Patients with Varicose Trophic Ulcers. Eur. J. Vasc. Endovasc. Surg, 58(6): 843.
13. Suzdalenko O., Voloshyn O. (2019) Hyperpigmentation After Sclerotherapy Management. Eur. J. Vasc. Endovasc. Surg., 58(6): 843–844.
14. Gohel M. S., Heatley F., Liu X. et al. (2018) A randomized trial of early endovenous ablation in venous ulceration. New Engl. J. Med., 378(22): 2105–2114.
15. Meissner M.H., Khilnani N.M., Labropoulos N. et al. (2021) The symptoms-varices-pathophysiology classification of pelvic venous disorders: a report of the American Vein & Lymphatic Society international working group on pelvic venous disorders. Phlebology, 36(5): 342–360.
16. De Maeseneer M., Pichot O., Cavezzi A. et al. (2011) Duplex ultrasound investigation of the veins of the lower limbs after treatment for varicose veins — UIP consensus document. Eur. J. Vasc. Endovasc. Surg., 42(1): 89–102.
17. Grünwald J., Ragg J.C. (2019) Perivascular hyaluronan-new cure for venous insufficiency. Eur. Congr. Radiol. — ECR.
18. Vos C.G., Ünlü Ç., Bosma J. et al. (2017) A systematic review and meta-analysis of two novel techniques of nonthermal endovenous ablation of the great saphenous vein. J. Vasc. Surg. Ven. Lymph. Dis., 5(6): 880–896.
19. Kahn S.R., Galanaud J.P., Vedantham S., Ginsberg J.S. (2016) Guidance for the prevention and treatment of the post-thrombotic syndrome. J. Thromb. Thrombolysis, 41(1): 144–153.
20. Azirar S., Appelen D., Prins M.H. et al. (2019) Compression therapy for treating post‐thrombotic syndrome. Cochrane Database of Systematic Reviews, 9.
21. Rabe E., Breu F.X., Cavezzi A. et al.; Guideline Group (2014) European guidelines for sclerotherapy in chronic venous disorders. Phlebology, 29(6): 338–354.
22. Lurie F., Passman M., Meisner M. et al. (2020) The 2020 update of the CEAP classification system and reporting standards. J. Vasc. Surg. Venous Lymph. Dis., 8(3): 342–352.
23. Passman M.A., McLafferty R.B., Lentz M.F. et al. (2011) Validation of venous clinical severity score (VCSS) with other venous severity assessment tools from the American venous forum, national venous screening program. J. Vasc. Surg., 54(6): 2–9.
24. Launois R., Mansilha A., Jantet G. (2010) International psychometric validation of the Chronic Venous Disease quality of life Questionnaire (CIVIQ-20). Eur. J. Vasc. Endovasc. Surg., 40(6): 783–789.